PREDICTION OF COMPLICATIONS DUE TO INTRATISSUE RADIOTHERAPY IN MULTIMODALITY TREATMENT FOR PROSTATE CANCER
https://doi.org/10.17650/1726-9776-2010-6-3-48-50
Abstract
The study of postbrachytherapy complications identified a number of factors that significantly influenced the development of lower urinary tract (LUT) complications. These factors may include prostate volume and preoperative degree of LUT symptoms. The combined effect of these factors increases a risk for the complications.
About the Authors
А. А. Kostin
Russian X-ray Radiology Research Center, Russian Agency for Medical Technologies, Moscow
Russian Federation
Russian Federation
A. V. Semin
Russian X-ray Radiology Research Center, Russian Agency for Medical Technologies, Moscow
Russian Federation
Russian Federation
A. D. Kaprin
Russian X-ray Radiology Research Center, Russian Agency for Medical Technologies, Moscow
Russian Federation
Russian Federation
A. D. Tsybulsky
Russian X-ray Radiology Research Center, Russian Agency for Medical Technologies, Moscow
Russian Federation
Russian Federation
References
1. Hudson R. Brachytherapy treatments increasing among Medicare population. Health Policy Brief of the American Urologic Association, Inc, 1999:9:1.
2. Ash D., Flynn A., Battermann J. et al. ESTRO/EAU/EORTC recommendations on permanent seed implantation for localized prostate cancer. Radiother Oncol 2000;57:315–21.
3. Blasko J.C., Grimm P.D., Sylvester J.E. Palladium-103 brachytherapy for prostate carcinoma. Int J Radiat Oncol Biol Phys 2000;46:839−50.
4. Grimm P.D., Blasko J.C., Sylsvester J.E. 10-year biochemical (PSA) control of prostate cancer with Iodine-125 brachytherapy. Int J Radiat Biol Phys 2001;51:31−40.
5. Ragde H., Korb L., Elgamal A. 12-year follow-up after transperineal brachytherapy of localized prostate cancer. J Urol Suppl 2000;163:336−7.
6. Ash D., Bottomley D., Al-Qaisieh B. et al. A prospective analysis of long-term quality of life after permanent I-125 brachythrapy for localised prostate cancer. Radiother Oncol 2007;84:135–9.
7. Bottomley D., Ash D., Al-Qaisieh B. et al. Side effects of permanent I-125 prostate seed implants in 667 patients treated in Leeds. Radiother Oncol 2007;82:46–9.
8. Brandeis J.M., Litwin M.S., Burnison C.M., Reiter R.E. Quality of life outcomes after brachytherapy for early stage prostate cancer. J Urol 2000;163:851–7.
9. Caffo O., Fellin G., Bolner A. et al. Prospective evaluation of quality of life after interstitial brachytherapy for localized prostate cancer. Int J Radiat Oncol Biol Phys 2006;66:31–7.
Review
For citations:
Kostin А.А., Semin A.V., Kaprin A.D., Tsybulsky A.D. PREDICTION OF COMPLICATIONS DUE TO INTRATISSUE RADIOTHERAPY IN MULTIMODALITY TREATMENT FOR PROSTATE CANCER. Cancer Urology. 2010;6(3):48-50. (In Russ.) https://doi.org/10.17650/1726-9776-2010-6-3-48-50
Views:
980
Email this article 